Vontobel Holding’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Other funds holding VIR
Vontobel Holding's VIR Position: Q3 2026 in Review
Vontobel Holding reduced its Vir Biotechnology (VIR) stake by 2% in Q3 2026, selling an estimated $7.54K and leaving 36,061 shares worth $403K. The position accounts for ﹤0.01% of the portfolio, ranked #1146.
Vontobel Holding first reported a position in VIR in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.4M in Q3 2021. 266 funds tracked by Wall St. Rank hold VIR as of Q3 2026.
- Vontobel Holding held 36,061 shares of Vir Biotechnology worth $403K as of Q3 2026.
- Vontobel Holding sold 754 Vir Biotechnology shares in Q3 2026, an estimated $7.54K.
- Vir Biotechnology made up ﹤0.01% of Vontobel Holding's portfolio in Q3 2026, its #1146 holding.
- Vontobel Holding first reported a position in Vir Biotechnology in Q4 2020 and has held it in 22 quarters since.
- Vontobel Holding's Vir Biotechnology position peaked at $1.4M in Q3 2021.
- 266 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.
Based on Vontobel Holding's 13F filing for Q3 2026, filed 16 Oct 2026.